Child Myopia Progression: When to Act | EMME Visioncare

Book an appointment with us for an eye check now
Book an Appointment
Blog - Article

Child Myopia Progression: When to Act

When Should Parents Worry About Myopia Progression?

Part of our myopia control for children in Singapore at The Cathay and Jelita Mall.

child-myopia-progression-screen-time

Last reviewed and updated: 21 September 2026

If your child is short-sighted, it is natural to wonder how much change is normal and when myopia progression should become a concern.

There is no single prescription change, age or eye measurement that tells every parent, “this is the point to worry”. Myopia progression needs to be interpreted in context. A child's age, previous prescription changes, axial length, family history, eye health and current management all help build a clearer picture.

What matters most is recognising progression early enough to monitor it properly and, where appropriate, discuss options for managing childhood myopia progression rather than waiting for the prescription to become much stronger.


What does myopia progression mean?

Myopia, or short-sightedness, means that distant objects appear blurred without appropriate vision correction. In most childhood myopia, this is associated with the eye growing longer from front to back.

Myopia progression means that the child's myopia is increasing over time. This may be seen as a change in spectacle prescription, an increase in axial length, or both.

These measurements describe related but different aspects of myopia:

  • Refractive error describes the optical prescription required for clear vision.
  • Axial length measures the physical length of the eye from front to back.

This distinction matters because a child's eye growth cannot always be understood fully from spectacle prescription alone.


When should parents pay closer attention?

Parents do not need to panic every time a child's prescription changes. However, certain patterns make closer assessment and monitoring worthwhile.

1. Your child's prescription keeps becoming more myopic

If a child repeatedly needs stronger minus-powered lenses over successive examinations, this suggests that the myopia is progressing.

The rate of change is more useful than looking at one prescription in isolation. Comparing today's findings with previous examinations allows the optometrist to establish whether the change appears relatively stable or whether a more persistent progression pattern is developing.

This is one reason it is useful to keep previous spectacle prescriptions and examination records where possible.

2. Myopia started at a younger age

Age is an important consideration in childhood myopia.

Research and clinical guidance consistently show that younger children with myopia generally have more years during which progression can occur, and younger age at onset is associated with a greater risk of faster progression and higher myopia later in life.

A child who becomes myopic relatively early therefore deserves careful monitoring even if the current prescription does not appear particularly strong.

This does not mean every young child will progress rapidly. It means that age forms part of the child's overall risk profile.

3. There is a strong family history of myopia

Children with one or both parents who are myopic have an increased likelihood of developing myopia, and family history is one of the factors considered when assessing a child's risk. 

Family history does not determine exactly how much an individual child's myopia will progress. Genetics interact with age, visual environment and other factors.

However, if a younger child is already myopic and there is significant myopia in the family, it is sensible to monitor progression rather than assuming that a pair of stronger glasses each year is the only consideration.

4. Axial length is increasing

Because childhood myopia is commonly associated with elongation of the eye, axial-length measurement can provide additional information about progression.

Axial length is measured in millimetres using optical biometry. The measurement is quick and non-invasive.

At EMME Visioncare, we measure axial length for every child undergoing a myopia assessment. Depending on the branch, measurements are performed using either the Topcon MYAH or Essilor ARK SW9000 optical biometry system.

The important point is the trend over time.

There is no single axial-length number that should be labelled normal or abnormal for every child. Age, refractive error, previous measurements, progression history and other clinical findings all affect interpretation.

For a fuller explanation, see what axial length means and why it matters in childhood myopia.

5. Myopia continues to progress despite current management

A child may already be using a myopia-control intervention and still show some progression.

This does not automatically mean the treatment has “failed”. Myopia-control treatments are designed to reduce the rate of progression; they cannot guarantee that eye growth will stop completely.

Response also varies between children.

When progression is detected during treatment, the practitioner may review factors such as:

  • changes in refractive error;
  • axial-length trend;
  • how consistently the treatment is being used;
  • lens fit or treatment performance where relevant;
  • the child's age and previous rate of progression;
  • eye health and other clinical findings; and
  • whether the current management plan remains appropriate.

Our article on how effective different myopia-control treatments can be explains why treatment-effect percentages should not be interpreted as a guarantee for an individual child.


Do parents need to wait for symptoms?

No.

A child does not necessarily notice that myopia is progressing gradually. They may simply adapt to slightly blurrier distance vision, move closer to the television or classroom board, or continue functioning until the prescription has changed enough to become obvious.

Some children may:

  • squint when looking into the distance;
  • sit unusually close to screens or distant targets;
  • complain that classroom writing is difficult to see;
  • notice that existing glasses are no longer as clear; or
  • show a change during a routine eye examination without having complained of symptoms.

Symptoms can therefore be useful clues, but they are not a reliable way to measure myopia progression.

Objective examination and comparison with previous findings are more useful.


How much progression is too much?

This is one of the most common questions parents ask, but there is no universal number that should be used as an alarm threshold for every child.

Research studies often classify progression using changes in refractive error or axial length over a defined period. Those thresholds are useful for research and clinical context, but an individual child should not be assessed from a single number alone.

For example, the same amount of change may have different significance in a younger child with several years of likely progression ahead compared with an older teenager whose myopia has begun to stabilise.

The more useful questions are:

  • How old is the child?
  • When did the myopia begin?
  • How has the prescription changed over previous visits?
  • How is the axial length changing?
  • Is there a family history of significant myopia?
  • Is the child already using myopia control?
  • Are the measurements consistent with one another?

This is why longitudinal monitoring is more meaningful than reacting to a single eye test.


Why does slowing progression matter?

The aim of myopia control is not simply to avoid thicker spectacles.

Higher levels of myopia and greater axial elongation are associated with a higher lifetime risk of several eye-health complications, including myopic macular changes, retinal detachment and glaucoma. 

That does not mean a child with myopia will develop these conditions. The purpose of myopia management is to reduce avoidable progression where possible and monitor eye development over time.

Current International Myopia Institute evidence reviews recognise multiple effective interventions for slowing childhood myopia progression, including optical and pharmacological approaches. Treatment selection should be individualised rather than assuming that one option is best for every child.


What can parents do at home?

Parents cannot accurately measure myopia progression at home, but there are useful things you can do between appointments.

  • Keep a record of your child's previous spectacle prescriptions.
  • Attend the recommended follow-up appointments rather than waiting until the glasses seem inadequate.
  • Make sure prescribed glasses, contact lenses or other myopia-control treatments are used as advised.
  • Encourage regular outdoor activity.
  • Encourage breaks from prolonged close work and screens.
  • Tell the optometrist if there is significant myopia in the family.
  • Ask how your child's prescription and axial length have changed since the previous visit.

Outdoor time is particularly well supported as a measure associated with reducing the risk of myopia onset. Once a child is already myopic, healthy visual habits remain worthwhile, but they should not be treated as a replacement for clinical assessment or evidence-based myopia-control treatment when progression is occurring.

For more practical guidance, see our article on screen time, outdoor time and childhood myopia.


What happens during a myopia assessment at EMME Visioncare?

A myopia assessment is intended to build a clearer picture of the individual child rather than simply checking whether a stronger pair of glasses is required.

Depending on the child's needs and clinical findings, assessment and monitoring may include:

  • reviewing previous prescriptions and progression history;
  • measuring refractive error and visual acuity;
  • assessing eye health;
  • measuring axial length;
  • reviewing family history and relevant visual habits;
  • considering the child's age and current stage of progression; and
  • discussing suitable management options where appropriate.

The objective is not simply to label progression as “good” or “bad”. It is to determine what the measurements mean for that particular child and whether closer monitoring or a change in management should be considered.


When should you arrange an assessment?

Consider arranging a myopia assessment if:

  • your child's prescription has repeatedly become more myopic;
  • myopia developed at a relatively young age;
  • one or both parents have significant myopia;
  • you are unsure how quickly the myopia is progressing;
  • your child is already using myopia control and you want to review the response;
  • axial length has not previously been measured or monitored; or
  • you would like to understand whether myopia-control options should be considered.

You do not need to wait until the prescription becomes “very high” before asking about progression.


The key takeaway

Parents should pay attention to childhood myopia when there is a pattern of progression, particularly in a younger child or where other risk factors are present.

However, there is no single prescription change or axial-length value that determines whether a child's myopia is concerning. The most useful approach is to compare measurements over time and interpret them together with the child's age, history and clinical findings.

If you are concerned about changes in your child's eyesight, you can learn more about myopia assessment and myopia-control options at EMME Visioncare.

You can also book an appointment at The Cathay or Jelita Mall for an assessment.


References

  1. Bullimore MA, Saunders KJ, Baraas RC, et al. IMI—Interventions for Controlling Myopia Onset and Progression 2025 . Investigative Ophthalmology & Visual Science. 2025;66(12):39.
  2. Gifford KL, Richdale K, Kang P, et al. IMI—Clinical Management Guidelines Report . Investigative Ophthalmology & Visual Science. 2019;60(3):M184–M203.
  3. Németh J, Tapasztó B, Aclimandos WA, et al. Update and guidance on management of myopia: European Society of Ophthalmology in cooperation with International Myopia Institute . European Journal of Ophthalmology. 2021;31(3):853–883.